Pfizer partners with Flagship in obesity
Pfizer Inc has entered into a partnership with a Cambridge, US, based venture capital group and its network of drug discovery and development companies, to identify proteins that might become the basis of new drugs for obesity. The venture capital group is Flagship Pioneering and the drug discovery activities are located at Pioneering Medicines, an in-house unit of Flagship, and Profound Therapeutics, a Flagship spin-off company. Pfizer has been collaborating with Pioneering Medicines since 2023.